AG
IBB icon

Advisor Group’s iShares Biotechnology ETF IBB Stock Holding History

Advisor Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$10.2M Sell
84,386
-382
-0.5% -$42.6K 0.07% 237
2019
Q3 		$8.44M Sell
84,768
-9,657
-10% -$1.01M 0.06% 260
2019
Q2 		$10.3M Sell
94,425
-2,602
-3% -$277K 0.08% 217
2019
Q1 		$10.8M Buy
97,027
+29,142
+43% +$3.2M 0.09% 197
2018
Q4 		$6.55M Sell
67,885
-6,008
-8% -$638K 0.06% 254
2018
Q3 		$9.01M Buy
73,893
+15,512
+27% +$1.83M 0.09% 196
2018
Q2 		$6.41M Sell
58,381
-2,667
-4% -$285K 0.09% 207
2018
Q1 		$6.52M Sell
61,048
-7,019
-10% -$778K 0.09% 202
2017
Q4 		$7.27M Buy
68,067
+210
+0.3% +$22.4K 0.1% 189
2017
Q3 		$7.55M Sell
67,857
-11,151
-14% -$1.19M 0.12% 168
2017
Q2 		$8.17M Buy
79,008
+1,470
+2% +$145K 0.14% 144
2017
Q1 		$7.58M Sell
77,538
-4,791
-6% -$459K 0.15% 141
2016
Q4 		$7.28M Buy
82,329
+7,788
+10% +$709K 0.16% 134
2016
Q3 		$7.19M Sell
74,541
-3,294
-4% -$313K 0.17% 127
2016
Q2 		$6.67M Buy
+77,835
New +$6.98M 0.18% 128

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisor Group's IBB Position: Q4 2019 in Review

Advisor Group reduced its iShares Biotechnology ETF (IBB) stake by 0.45% in Q4 2019, selling an estimated $42.6K and leaving 84,386 shares worth $10.2M. The position accounts for 0.07% of the portfolio, ranked #237.

Advisor Group first reported a position in IBB in Q2 2016 and has held it in 15 quarters since. The position peaked at $10.8M in Q1 2019. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

  • Advisor Group held 84,386 shares of iShares Biotechnology ETF worth $10.2M as of Q4 2019.
  • Advisor Group sold 382 iShares Biotechnology ETF shares in Q4 2019, an estimated $42.6K.
  • iShares Biotechnology ETF made up 0.07% of Advisor Group's portfolio in Q4 2019, its #237 holding.
  • Advisor Group first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's iShares Biotechnology ETF position peaked at $10.8M in Q1 2019.
  • 710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.